[HTML][HTML] Cholangiocarcinoma

PJ Brindley, M Bachini, SI Ilyas, SA Khan… - Nature reviews Disease …, 2021 - nature.com
Cholangiocarcinoma (CCA) is a highly lethal adenocarcinoma of the hepatobiliary system,
which can be classified as intrahepatic, perihilar and distal. Each anatomic subtype has …

Metabolic reprogramming and its clinical implication for liver cancer

F Yang, L Hilakivi-Clarke, A Shaha, Y Wang, X Wang… - Hepatology, 2023 - journals.lww.com
Cancer cells often encounter hypoxic and hypo-nutrient conditions, which force them to
make adaptive changes to meet their high demands for energy and various biomaterials for …

Mitochondrial oxidative metabolism contributes to a cancer stem cell phenotype in cholangiocarcinoma

C Raggi, ML Taddei, E Sacco, N Navari, M Correnti… - Journal of …, 2021 - Elsevier
Background & Aims Little is known about the metabolic regulation of cancer stem cells
(CSCs) in cholangiocarcinoma (CCA). We analyzed whether mitochondrial-dependent …

The role of gut microbiome-derived short chain fatty acid butyrate in hepatobiliary diseases

K Pant, SK Venugopal, MJL Pisarello… - The American Journal of …, 2023 - Elsevier
The multiple beneficial effects of the short-chain fatty acid (SCFA) butyrate on human health,
produced from fermentable carbohydrates by gut microbiota in the colon, are well known. At …

[HTML][HTML] New molecular mechanisms in cholangiocarcinoma: signals triggering interleukin-6 production in tumor cells and KRAS co-opted epigenetic mediators …

L Colyn, G Alvarez-Sola, MU Latasa, I Uriarte… - Journal of Experimental …, 2022 - Springer
Background Cholangiocarcinoma (CCA) is still a deadly tumour. Histological and molecular
aspects of thioacetamide (TAA)-induced intrahepatic CCA (iCCA) in rats mimic those of …

[HTML][HTML] Metabolic reprogramming induced by DCA enhances cisplatin sensitivity through increasing mitochondrial oxidative stress in cholangiocarcinoma

H Qin, G Zheng, Q Li, L Shen - Frontiers in Pharmacology, 2023 - frontiersin.org
Background: Cholangiocarcinoma has obvious primary multidrug resistance and is
generally resistant to cisplatin and other chemotherapy drugs and high glycolytic levels may …

Intrahepatic cholangiocarcinoma: Morpho-molecular pathology, tumor reactive microenvironment, and malignant progression

AE Sirica, M Strazzabosco, M Cadamuro - Advances in cancer research, 2021 - Elsevier
Intrahepatic cholangiocarcinoma (iCCA) is a relatively rare, but highly lethal and biologically
complex primary biliary epithelial cancer arising within liver. After hepatocellular carcinoma …

[HTML][HTML] The Ubiquitin–Proteasome System in Tumor Metabolism

J Wang, Y Xiang, M Fan, S Fang, Q Hua - Cancers, 2023 - mdpi.com
Simple Summary The reprogramming of tumor cell metabolism is an important char acteristic
of cancer, which provides the energy and biomacromolecules in tumor development …

[HTML][HTML] Intrahepatic cholangiocarcinoma biomarkers: Towards early detection and personalized pharmacological treatments

M Capuozzo, M Santorsola, F Ferrara, C Cinque… - Molecular and Cellular …, 2024 - Elsevier
Cholangiocarcinoma (CCA) is a rare malignancy originating from the biliary tree and is
anatomically categorized as intrahepatic (iCCA), perihilar, and extrahepatic or distal. iCCA …

Metabolic disorders and the risk of cholangiocarcinoma

M Ghidini, D Ramai, A Facciorusso… - Expert Review of …, 2021 - Taylor & Francis
Introduction: Cholangiocarcinoma (CCA) is a malignancy which arises from the biliary
epithelium. Carcinogenesis of CCA is mainly linked to aberrant glucose metabolism and …